Astellas Pharma

Highly Engaged Employees

Astellas Pharma, founded in 1923 and publicly traded under the ticker TYO: 4503, is a global pharmaceutical company headquartered in Tokyo, Japan. The company is dedicated to the manufacturing, marketing, import, and export of pharmaceuticals, focusing on developing innovative new drugs and therapies. Its core business revolves around biopharmaceutical research and development, aiming to address unmet medical needs and improve patient outcomes worldwide. Astellas Pharma operates within the Healthcare and Pharmaceuticals industry, leveraging its extensive history and scientific expertise to advance medical science.

With a significant global footprint, Astellas Pharma operates across 36 locations worldwide, demonstrating a broad operational reach. The company employs over 10,000 individuals, reflecting its substantial scale and capacity in the pharmaceutical sector. Its commitment to innovation is evident in its product pipeline, which includes advanced treatments such as cell therapy, gene therapy, and novel drug candidates. For detailed insights into its geographic presence and operational centers, Learn about Astellas Pharma's global headquarters provides further information.

Astellas Pharma generates substantial revenue, reporting $12.7B, underscoring its strong market position. The company has a history of significant funding, including multiple venture capital rounds like Series A, B, and C, indicating investor confidence in its growth potential and R&D pipeline. It competes with major industry players such as Janssen, Amgen, and Takeda Pharmaceutical Company, among others. To understand its financial performance and strategic investments, interested parties can Explore financial highlights. Furthermore, to gain insight into the leadership driving these initiatives, one can Meet Astellas Pharma's team.